Clinical Trials Logo
  1. Home
  2. Iron Overload
  3. NCT01376622
  4. Details
NCT01376622 Clinical Trial

Changes in Pituitary Iron and Volume With Deferasirox

Iron Overload Clinical Trial

Official title:
Changes in Pituitary Iron and Volume With Deferasirox in Transfusional Iron Overload

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01376622
Other study ID # CCI-08-00143
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 2008
Est. completion date July 1, 2011

Study information
Verified date October 2023
Source Children's Hospital Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Despite continuing advances in iron chelation therapy, iron toxicity of endocrine glands, particularly the pituitary gland, remains common in patients with transfusion dependent anemias. We would like to establish accurate population norms of pituitary R2 and volume and understand the progression of pituitary iron in transfused patients on Deferasirox.

Recruitment information / eligibility
Status Completed
Enrollment 130
Est. completion date July 1, 2011
Est. primary completion date July 1, 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 25 Years
Eligibility Inclusion Criteria: - Currently on chronic transfusion therapy. - Duration of chronic transfusion >1 year. - Age 2 to 25 years - On deferasirox monotherapy for the duration of the study. - Informed consent from legal guardian and/or patient. - On deferasirox for a minimum of 3 months at start of study. Exclusion Criteria: - Sickle cell disease or sickle-beta zero genotype. - Combination of deferasirox and another iron chelator.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Children's Hospital Los Angeles Los Angeles California

Sponsors (2)
Lead Sponsor Collaborator
Children's Hospital Los Angeles Novartis Pharmaceuticals

Country where clinical trial is conducted

United States, 

References & Publications (1)

Wood JC, Noetzl L, Hyderi A, Joukar M, Coates T, Mittelman S. Predicting pituitary iron and endocrine dysfunction. Ann N Y Acad Sci. 2010 Aug;1202:123-8. doi: 10.1111/j.1749-6632.2010.05545.x. — View Citation

See also
  Status Clinical Trial Phase
Recruiting NCT04423237 - Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT
Completed NCT04614779 - Long-term Clinical Study of CN128 in Thalassemia Patients Phase 2
Withdrawn NCT03800446 - Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood N/A
Not yet recruiting NCT02833493 - Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload N/A
Completed NCT02164253 - Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients Phase 2
Completed NCT00512226 - Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia N/A
Completed NCT00901199 - Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload Phase 2
Recruiting NCT00378469 - Study of the Effects of Muscular Activity on Iron Metabolism N/A
Completed NCT00117507 - Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients Phase 4
Completed NCT00138684 - Cytochrome P450 2E1 and Iron Overload Phase 2
Completed NCT03990181 - Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement N/A
Terminated NCT02274233 - Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia Phase 1
Active, not recruiting NCT01443195 - Iron Metabolism in Small Pre Term Newborns N/A
Completed NCT01546415 - Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia Phase 4
Completed NCT01572818 - Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients N/A
Not yet recruiting NCT00980421 - Safety of Various Mode of Delivery of Iron Supplement on Iron Toxicity Markers in Preschool Children Phase 3
Completed NCT01047098 - Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation N/A
Recruiting NCT05294471 - Fully Automated High-Throughput Quantitative MRI of the Liver
Completed NCT03591575 - Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children Phase 4
Active, not recruiting NCT00907283 - Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) Phase 2